Relafen 750, chemically known as naproxen salt, represents a fascinating illustration within the biochemical area of pain alleviation. Its mechanism of action involves the specific inhibition of cyclooxygenase-2 (COX-2), an enzyme critical for the synthesis of inflammatory mediators . Unlike non-

Considering a cellular clinical viewpoint, Relafen 750 (Naproxen) exhibits unique behaviors. It works primarily as a cyclooxygenase agent, preferentially blocking cyclooxygenase-2 (COX-2), an enzyme participating in prostaglandin formation. This targeted inhibition leads to decreased inflammation